Omeros Corp
OMER- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001285819
In the last 90 days, Omeros Corp insiders filed 0 open-market purchases and 6 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $343.0M in total; no superinvestor holds it.
Superinvestors holding OMER, Q2 2026
No superinvestor reported holding OMER in Q2 2026.